Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_4
1
17%
Ph phase_3
2
33%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_4

Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes

NCT01486966
completed

NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

NCT01492153
completed

Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

NCT01542489
completedphase_3

Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

NCT01486940
completedphase_3

Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

NCT01707134
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01486966Phase 4

Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes

Terminated
NCT01492153

NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

Completed
NCT01542489

Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

Completed
NCT01486940Phase 3

Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

Completed
NCT01707134Phase 3

Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

Completed
NCT02162407Phase 1

A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6